These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3921945)

  • 1. Insulin infusion therapy. Potential benefits and risks.
    Bonner RA
    Postgrad Med; 1985 May; 77(6):153-64. PubMed ID: 3921945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
    Boel E; Selmer J; Flodgaard HJ; Jensen T
    J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion as a treatment option: a perspective after seven years of research applications.
    Pickup JC
    Diabet Med; 1984 May; 1(1):27-32. PubMed ID: 6242772
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion (CSII): therapeutic options.
    Ward JD
    Diabet Med; 1984 May; 1(1):47-50. PubMed ID: 6242777
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of the insulin pump in children.
    Cornwell S; MacDonald MJ
    Prim Care; 1983 Dec; 10(4):723-50. PubMed ID: 6371865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of metabolic control to complications in diabetes mellitus.
    Leslie ND; Sperling MA
    J Pediatr; 1986 Apr; 108(4):491-7. PubMed ID: 3514827
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin pumps--still a research tool?
    Lauritzen T; Pramming S
    Ann Clin Res; 1984; 16(2):98-106. PubMed ID: 6380393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intensified insulin therapy by multiple injections or by pump].
    Pernet A
    Schweiz Med Wochenschr; 1986 Jan; 116(3):77-82. PubMed ID: 3511525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 36 months continuous subcutaneous insulin infusion (CSII) in insulin dependent diabetes (IDDM)--influence on early stages of retinopathy, nephropathy and neuropathy--psychological analysis.
    Bibergeil H; Hüttl I; Felsing W; Felsing U; Seidlein I; Herfurth S; Dabels J; Reichel G; Lüder C; Albrecht G
    Exp Clin Endocrinol; 1987 Aug; 90(1):51-61. PubMed ID: 3666060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of artificial pancreas and portable insulin infusion pumps in diabetes therapy: past, present, and future.
    Pfeiffer EF; Kerner W
    Artif Organs; 1985 May; 9(2):129-37. PubMed ID: 4015447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of diabetic peripheral neuropathy with the portable insulin infusion pump.
    Tolaymat A; Roque JL; Russo LS
    South Med J; 1982 Feb; 75(2):185-9. PubMed ID: 7036357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous subcutaneous insulin infusion therapy. Prerequisites, indications and risks].
    Sonnenberg GE; Spraul M; Chantelau EA; Berger M
    Dtsch Med Wochenschr; 1985 Nov; 110(48):1859-64. PubMed ID: 3933943
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin infusion pump treatment of Type I diabetes.
    Tamborlane WV; Press CM
    Pediatr Clin North Am; 1984 Jun; 31(3):721-34. PubMed ID: 6374595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continuous subcutaneous insulin infusion; the first decade].
    Doorenbos H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):91-3. PubMed ID: 3821988
    [No Abstract]   [Full Text] [Related]  

  • 15. Newer approaches to the control of the insulin-dependent diabetic patient.
    Bergman M; Felig P
    Dis Mon; 1983 Apr; 29(7):1-65. PubMed ID: 6403321
    [No Abstract]   [Full Text] [Related]  

  • 16. Problems and safety of continuous subcutaneous insulin infusion.
    Home PD; Marshall SM
    Diabet Med; 1984 May; 1(1):41-4. PubMed ID: 6242775
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute complications associated with the use of insulin infusion pumps.
    Mecklenburg RS
    Diabetes Educ; 1989; 15(1):40-3. PubMed ID: 2491989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy.
    Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P
    Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous subcutaneous insulin infusion].
    Araki H; Makino H; Yoshida S
    Nihon Rinsho; 1990 Dec; 48 Suppl():1038-43. PubMed ID: 2086865
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of direct cost of standard compared with intensive insulin treatment of insulin-dependent diabetes mellitus and cost of complications.
    Stern Z; Levy R
    Acta Diabetol; 1996 Mar; 33(1):48-52. PubMed ID: 8777285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.